Syneos Health to Present at Upcoming Investor Conferences

Rhea-AI Summary

Syneos Health (Nasdaq:SYNH) announced its participation in two investor conferences. CFO Jason Meggs will present at the Credit Suisse Virtual Healthcare Conference on November 9, 2020, at 9:30 a.m. EST. CEO Alistair Macdonald and CFO Jason Meggs will present at the Jefferies Virtual London Healthcare Conference on November 19, 2020, at 11:25 a.m. EST/4:25 p.m. GMT. Live webcasts and presentation materials will be available on the Company's Investor Relations website.

Syneos Health provides integrated biopharmaceutical solutions globally, combining clinical and commercial expertise.

News Market Reaction – SYNH

+3.76%

+3.76% Session move

In the trading session that priced this news, SYNH gained 3.76%, reflecting a moderate positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

MORRISVILLE, N.C., Nov. 02, 2020 (GLOBE NEWSWIRE) -- Syneos Health^® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization combining a CRO (Contract Research Organization) and a CCO (Contract Commercial Organization), today announced that management is scheduled to present at two upcoming investor conferences:

• Credit Suisse Virtual Healthcare Conference: Chief Financial Officer Jason Meggs is scheduled to present on Monday, November 9, 2020, at 9:30 a.m. EST.
• Jefferies Virtual London Healthcare Conference: Chief Executive Officer Alistair Macdonald and Chief Financial Officer Jason Meggs are scheduled to present on Thursday, November 19, 2020, at 11:25 a.m. EST/4:25 p.m. GMT.

A live webcast of each event, along with presentation materials and archived audio replays of each presentation will be available on the Company’s Investor Relations website at investor.syneoshealth.com.

About Syneos Health
Syneos Health^® (Nasdaq:SYNH) is the only fully integrated biopharmaceutical solutions organization. The Company, including a Contract Research Organization (CRO) and Contract Commercial Organization (CCO), is purpose-built to accelerate customer performance to address modern market realities. We bring together approximately 24,000 clinical and commercial minds with the ability to support customers in more than 110 countries. Together we share insights, use the latest technologies and apply advanced business practices to speed our customers’ delivery of important therapies to patients. To learn more about how we are shortening the distance from lab to life^®, visit syneoshealth.com or subscribe to our podcast.

Contacts

Investor Relations:	Press/Media:
Ronnie Speight	Danielle DeForge
Senior Vice President, Investor Relations	Vice President, External Communications
+1 919 745 2745	+1 202 210 5992
Investor.Relations@syneoshealth.com	danielle.deforge@syneoshealth.com

FAQ

What is the date and time of the Credit Suisse Virtual Healthcare Conference presentation by SYNH?

The presentation by CFO Jason Meggs is scheduled for November 9, 2020, at 9:30 a.m. EST.

When will SYNH present at the Jefferies Virtual London Healthcare Conference?

SYNH will present on November 19, 2020, at 11:25 a.m. EST/4:25 p.m. GMT.

Where can I watch the SYNH conference presentations?

You can watch the live webcasts and find presentation materials on the Company's Investor Relations website.

What does Syneos Health (SYNH) focus on?

Syneos Health focuses on providing integrated biopharmaceutical solutions, combining a CRO and CCO model.

How many countries does Syneos Health (SYNH) operate in?

Syneos Health operates in more than 110 countries.